Department of Health
and Human Services (HHS)
and Human Services (HHS)
March 25, 2021
PAR-20-083 - Enhancing Regulatory Science for Advancing Pharmaceutical Quality and Manufacturing (U01) Clinical Trials Optional
U.S. Food and Drug Administration (FDA)
This Notice is to extend the Application Due Dates for PAR-20-083 titled "Enhancing Regulatory Science for Advancing Pharmaceutical Quality and Manufacturing (U01) Clinical Trials Optional.”
The New Application Due Dates are:
New Application Due Date(s)
April 5, 2021, by 11:59 PM Eastern Time.
April 4, 2022, by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
Shashi Malhotra
Food and Drug Administration
Office of Operations, Office of Finance Budget & Acquisitions
Office of Grants and Acquisition Services
Tel: 301-402-7592
Email: Shashi.Malhotra@fda.hhs.gov